Graham Capital Management, L.P. Amgen Inc Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $302,493 - $341,248	1,183 Added 47.62%	3,667 $1.06 Million
Q3 2023 Nov 22, 2023	BUY	$218.65 - $271.46 $244,232 - $303,220	1,117 Added 81.71%	2,484 $667,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $292,907 - $346,356	1,367 New	1,367 $303,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $220,804 - $244,267	-1,007 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $200,272 - $229,193	1,007 New	1,007 $226,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.